Research funding
- Australian Bladder Foundation - Moro, 2017-2018
“Alternative pharmaceutical treatments for bladder management: An investigation into the potential for histamine and prostaglandin targets” - Quality Use of Medicines Network, Collaborative Research Funding scheme – Chess- Williams, McDermott, Sellers & Dukie, 2017
“Prostate cancer and alpha-adrenoceptor antagonists” - Cancer Council Queensland - Chess-Williams, McDermott & Rose Myer, 2012-2014
"Cytotoxic drugs: cellular and tissue effects and the effects of ageing" - NHMRC - Chess-Williams, Burcher, Moore, Mansfield, 2009-2012
“Non-neuronal ATP: regulation of release and action in the bladder” - Pfizer Overactive Bladder Competitive Grant Program - Chess-Williams, 2008-2010
"Muscarinic receptor mediated release of nitric oxide, its effect on urothelial spontaneous activity and role in the idiopathic overactive bladder” - European Commission Framework 7 - Marie Curie Initial Training Networks, 2010-2014
11 European centres – Sheffield Hallam University centre 2 - Sellers, McKay & Grundy
“Training for Urology Scientists to develop new Treatments (TRUST)” - Pfizer Investigator Initiated Research (IIR) Program - Collins, Sellers, McKay, Grundy, Chapple, 2009-2010
“Antimuscarinics: effects on mucosal-afferent signalling pathways?”
Editorial boards
Current
- Journal of Pharmacological & Toxicological Methods (D. Sellers)
- Naunyn Schmeidebergs Archives of Pharmacology (R. Chess-Williams)
Past
- Life Sciences (D. Sellers)
- Frontiers in Autonomic Neuroscience (R. Chess-Williams)
- Autonomic & Autocoid Pharmacology (R. Chess-Williams)